Form D Explorer

Inspect source fieldsReport a record issue

Form D/A — Imbria Pharmaceuticals, Inc.

0001104659-25-121539 · filed Dec 16, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$144,195,814
Reported amount sold
$66,695,817
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Imbria Pharmaceuticals, Inc.
CIK
1745672
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
265 FRANKLIN STREET
BOSTON, Massachusetts 02110
Phone
917-657-5069

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗